Coronavirus (COVID-19) Update: FDA Warns Seller Marketing Dangerous Chlorine Dioxide Products that Claim to Treat or Prevent COVID-19April 8, 2020
FDA Approves First Generic of a Commonly Used Albuterol Inhaler to Treat and Prevent BronchospasmApril 8, 2020
Coronavirus (COVID-19) Update: FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19April 3, 2020
Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the PandemicApril 2, 2020
FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia A or B and InhibitorsApril 1, 2020
Coronavirus (COVID-19) Update: FDA Continues to Accelerate Development of Novel Therapies for COVID-19March 31, 2020
Coronavirus (COVID-19) Update: FDA expedites review of diagnostic tests to combat COVID-19March 30, 2020
FDA on Signing of the COVID-19 Emergency Relief Bill, Including Landmark Over-the-Counter Drug Reform and User Fee LegislationMarch 30, 2020
Coronavirus (COVID-19) Update: FDA takes further steps to help mitigate supply interruptions of food and medical productsMarch 28, 2020
